[go: up one dir, main page]

ITMI20022777A1 - Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. - Google Patents

Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Info

Publication number
ITMI20022777A1
ITMI20022777A1 IT002777A ITMI20022777A ITMI20022777A1 IT MI20022777 A1 ITMI20022777 A1 IT MI20022777A1 IT 002777 A IT002777 A IT 002777A IT MI20022777 A ITMI20022777 A IT MI20022777A IT MI20022777 A1 ITMI20022777 A1 IT MI20022777A1
Authority
IT
Italy
Prior art keywords
procedures
obtaining
thyroid hormones
pharmaceutical formulations
thyroid
Prior art date
Application number
IT002777A
Other languages
English (en)
Inventor
Martino Alessandro Di
Alberto Garavani
Maurizio Marchiorri
Angel Mateo
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32448935&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI20022777(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altergon Sa filed Critical Altergon Sa
Priority to IT002777A priority Critical patent/ITMI20022777A1/it
Priority to US10/746,386 priority patent/US7691411B2/en
Priority to EP03029729A priority patent/EP1433478B1/en
Priority to DK03029729.5T priority patent/DK1433478T3/da
Priority to DE60329968T priority patent/DE60329968D1/de
Priority to AT03029729T priority patent/ATE447939T1/de
Priority to ES03029729T priority patent/ES2334777T3/es
Priority to SI200331747T priority patent/SI1433478T1/sl
Priority to CA2454050A priority patent/CA2454050C/en
Priority to JP2003432097A priority patent/JP4851064B2/ja
Publication of ITMI20022777A1 publication Critical patent/ITMI20022777A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT002777A 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento. ITMI20022777A1 (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
CA2454050A CA2454050C (en) 2002-12-27 2003-12-23 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
DE60329968T DE60329968D1 (de) 2002-12-27 2003-12-23 Dosierungsformen enthaltend Thyroidhormone und deren Herstellungsverfahren
EP03029729A EP1433478B1 (en) 2002-12-27 2003-12-23 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
DK03029729.5T DK1433478T3 (da) 2002-12-27 2003-12-23 Farmaceutiske formler til thyroidhormoner og fremgangsmåder til opnåelse af disse
US10/746,386 US7691411B2 (en) 2002-12-27 2003-12-23 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them
AT03029729T ATE447939T1 (de) 2002-12-27 2003-12-23 Dosierungsformen enthaltend thyroidhormone und deren herstellungsverfahren
ES03029729T ES2334777T3 (es) 2002-12-27 2003-12-23 Formulas farmaceuticas para hormonas tiroideas y procedimientos para su obtencion.
SI200331747T SI1433478T1 (sl) 2002-12-27 2003-12-23 Farmacevtske formulacije za tiroidne hormone in postopki za njihovo pripravo
JP2003432097A JP4851064B2 (ja) 2002-12-27 2003-12-26 甲状腺ホルモン用医薬形態およびそれを得るための方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Publications (1)

Publication Number Publication Date
ITMI20022777A1 true ITMI20022777A1 (it) 2004-06-28

Family

ID=32448935

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002777A ITMI20022777A1 (it) 2002-12-27 2002-12-27 Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.

Country Status (10)

Country Link
US (1) US7691411B2 (it)
EP (1) EP1433478B1 (it)
JP (1) JP4851064B2 (it)
AT (1) ATE447939T1 (it)
CA (1) CA2454050C (it)
DE (1) DE60329968D1 (it)
DK (1) DK1433478T3 (it)
ES (1) ES2334777T3 (it)
IT (1) ITMI20022777A1 (it)
SI (1) SI1433478T1 (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7163918B2 (en) * 2000-08-22 2007-01-16 New River Pharmaceuticals Inc. Iodothyronine compositions
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
BRPI0416639A (pt) * 2003-11-19 2007-01-16 Metabasis Therapeutics Inc tiromiméticos contendo fósforo
ITMI20041317A1 (it) * 2004-06-30 2004-09-30 Ibsa Inst Biochimique Sa Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
JP2008542301A (ja) 2005-05-26 2008-11-27 メタバシス・セラピューティクス・インコーポレイテッド 脂肪性肝疾患の処置のための甲状腺ホルモン様薬剤
CA2606498C (en) * 2005-05-26 2016-08-09 Metabasis Therapeutics, Inc. Novel phosphinic acid-containing thyromimetics
IT1395454B1 (it) * 2009-03-24 2012-09-21 Altergon Sa Composizioni e forme farmaceutiche per somministrazione orale di ormoni tiroidei in grado di contrastare l'azione di agenti sequestranti nel tratto gastrointestinale
CN107635546B (zh) * 2015-05-19 2020-08-25 阿尔特刚股份有限公司 四碘甲状腺原氨酸的液体药物制剂
WO2018094265A2 (en) 2016-11-21 2018-05-24 Viking Therapeutics, Inc. Method of treating glycogen storage disease
CN110996966A (zh) 2017-06-05 2020-04-10 维京治疗公司 用于治疗纤维化的组合物
CA3094167A1 (en) 2018-03-22 2019-09-26 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
EP3890747A4 (en) 2018-12-05 2022-08-03 Viking Therapeutics, Inc. COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND INFLAMMATION
KR20220154196A (ko) * 2020-03-18 2022-11-21 알.피.쉐러 테크놀러지즈 엘엘씨 연질겔 캡슐

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6191M (it) 1966-02-18 1968-07-22
DE4026600A1 (de) * 1990-08-23 1992-02-27 Henning Berlin Gmbh Mittel zur tsh-suppression und behandlung von struma
JPH0952850A (ja) * 1995-06-09 1997-02-25 Meiji Seika Kaisha Ltd グミ製剤
JPH10130140A (ja) * 1996-11-01 1998-05-19 Meiji Seika Kaisha Ltd グミ製剤の製造方法
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
AU772153B2 (en) * 1999-02-12 2004-04-08 Molecular Insight Pharmaceuticals, Inc. Matrices for drug delivery and methods for making and using the same
JP2000279107A (ja) * 1999-03-30 2000-10-10 Lion Corp 非う蝕性易嚥下組成物並びにそれを用いた食品用組成物及び医薬品用組成物
US6852688B2 (en) * 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
US6790453B2 (en) * 2001-03-14 2004-09-14 Mccormick & Company, Inc. Encapsulation compositions and process for preparing the same
GB0111314D0 (en) 2001-05-09 2001-07-04 Karobio Ab Dermatological formulations
ITMI20011401A1 (it) 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei

Also Published As

Publication number Publication date
JP2004210780A (ja) 2004-07-29
EP1433478A1 (en) 2004-06-30
US20040219218A1 (en) 2004-11-04
DE60329968D1 (de) 2009-12-24
DK1433478T3 (da) 2010-02-01
ATE447939T1 (de) 2009-11-15
ES2334777T3 (es) 2010-03-16
JP4851064B2 (ja) 2012-01-11
SI1433478T1 (sl) 2010-03-31
EP1433478B1 (en) 2009-11-11
CA2454050A1 (en) 2004-06-27
CA2454050C (en) 2013-01-29
US7691411B2 (en) 2010-04-06

Similar Documents

Publication Publication Date Title
NO20063430L (no) Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
SE0301700D0 (sv) Novel compounds
NO20063429L (no) Brusende oral opiat doseringsform
ITMI20022777A1 (it) Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
HRP20041152B1 (hr) Farmaceutske formulacije
HUS1600021I1 (hu) MEK inhibitorok és módszerek azok felhasználására
CY1112721T1 (el) Νεοι συνδετες που διαμορφωνουν τους υποδοχεις rαr, και χρηση αυτων στην ιατρικη για τον ανθρωπο και στα καλλυντικα
CY1110558T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
WO2007149406A3 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
CR7362A (es) Formulaciones farmaceuticas de derivado de platino
ATE413162T1 (de) Pharmazeutische zusammensetzungen zur sicheren verabreichung von bei der behandlung von drogenabhängigkeit verwendeten arzneimitteln
DK1291021T3 (da) Farmaceutiske formuleringer som omfatter thyroideahormoner
CY1105028T1 (el) Υποκατεστημενες c-ιμιδαζο-[1,2-α]πυριδιν-3-υλο-μεθυλαμινες
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
NO331082B1 (no) Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
EP1503748A4 (en) DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY
SE0200657D0 (sv) Novel Formulation
ATE433450T1 (de) Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen
DK1273301T3 (da) Farmaceutiske præparater baseret på aktive bestanddele der kan anvendes til ulovlig administration
ATE530172T1 (de) Pharmazeutische formulierungen mit clopidogrel